Circulating Tumour DNA Reflects Tumour Burden Independently of Adverse Events Caused by Systemic Therapies for Melanoma
DOI:
https://doi.org/10.2340/00015555-3279Keywords:
biomarker, BRAF, circulating tumor DNA, LDH, melanomaAbstract
Abstract is missing (Short communication)Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Atsuko Ashida, Kaori Sakaizawa, Asuka Mikoshiba, Yukiko Kiniwa, Ryuhei Okuyama
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.